valsartan has been researched along with Sickle Cell Trait in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andemariam, B; Jones, SM; Lykotrafitis, G; Zhang, J | 1 |
1 other study(ies) available for valsartan and Sickle Cell Trait
Article | Year |
---|---|
Valsartan impedes epinephrine-induced ICAM-4 activation on normal, sickle cell trait and sickle cell disease red blood cells.
Topics: Adolescent; Adult; Animals; Cell Adhesion Molecules; Chlorocebus aethiops; COS Cells; Epinephrine; Erythrocyte Membrane; Erythrocytes, Abnormal; Female; HEK293 Cells; Humans; Male; Mice; Microscopy, Atomic Force; Receptor, Angiotensin, Type 1; Sickle Cell Trait; Valsartan | 2019 |